Thermo Fisher’s Oncomine gains FDA approval as brain tumor diagnostic
As a companion diagnostic, Oncomine will be used to identify patients eligible for treatment with Servier’s Voranigo.
As a companion diagnostic, Oncomine will be used to identify patients eligible for treatment with Servier’s Voranigo.
What's Your Reaction?
